North America Dental Biomaterials Market

North America Dental Biomaterials Market Size (2022 to 2027)

The size of the dental biomaterials market in the North American region is predicted to register a CAGR of 6.53% from 2022 to 2027 and be worth USD 4.12 billion by 2027 from USD 3 billion in 2022.

The increase in research and development institutes to develop revolutionary medical procedures is saturating the North American market's demand. Furthermore, biomaterials play an important part in restoring or replacing a tissue function in the body, another factor driving the market's expansion. In addition, the increasing prevalence of innovative biomaterials and their innovations, along with the rising beauty consciousness and a growing preference for plastic surgery, is driving market growth in North America.

Growing demand for better treatment or diagnostic methods in the medical sector is another key factor expected to favor the North American market during the forecast period. Furthermore, rising rates of chronic diseases and other infectious disorders present opportunities for the industry. Moreover, an increase in money from private and public entities substantially impacts market demand. In addition, a greater emphasis on developing novel items with cutting-edge technology and assuring improved treatment processes is expected to support the market's demand.

The market players in this region are entering into acquisitions to extend their product and service platforms. In addition, the dentistry sector has consolidated due to global companies acquiring key regional players. These factors are predicted to drive the North American dental biomaterials market during the forecast period.

The market's expansion is being slowed by a lack of understanding about the optimum materials to use. The laboratory equipment takes a significant amount of installation and maintenance, which has proven to be a difficult attribute for North American Biomaterials market entrepreneurs. In addition, the government's strict laws and regulations, which are concerned about patient health conditions, are limiting the market's expansion. The market for dental biomaterials in North America has been hit hard in recent months due to significant disruptions in their separate production and supply-chain operations as a result of numerous precautionary lockdowns and other limitations imposed by governments across the continent.

This report on the North American dental biomaterials market has been segmented and sub-segmented into the following categories.

By Type:

• Metallic Biomaterials
  • Titanium
  • Stainless Steel
  • Chromium Alloys
  • Others
• Ceramic Biomaterials
• Polymeric Biomaterials
• Metal-Ceramic Biomaterials
• Natural Biomaterials
• Composites Biomaterials

By Application:

• Implantology
• Orthodontics
• Prosthodontics

By End-User:

• Dental Implant and Prosthetic Manufacturers
• Dental Laboratories
• Dental Hospitals & Clinics
• Dental Academics & Research Institutes

By Country:

• The United States
• Canada
• Rest of North America

During the projection period, the North American biomaterials market is expected to grow rapidly and become the best-performing region in the global dental biomaterials market. With the help of any implanted gadget, the quality of many patients' lives has improved in a short period across the continent. Metals, ceramics, polymers, and various composites are some of the materials used to construct these devices. Moreover, the success of these materials is increasing as we approach the end of the twentieth century, thanks to improved surgical capabilities and a better understanding of how the body interacts with them.

Over the last decade, the dental biomaterials market in the United States had the largest market share and is likely to continue rising in the foreseeable future. A rise in capital income is one of the factors fuelling market demand. In addition, the rising number of people with cardiovascular problems is expected to surpass the growth of the biomaterials market in the United States.

The Canadian dental biomaterials market is ranked second in the top dominant shares in the North American region, owing to the growth of pharmaceutical companies' size. The government's increasing investments in hospital development boost the market's growth. In addition, the market's demand is quickening due to the rising desire for higher-quality medical items.

KEY MARKET PLAYERS:

Straumann Holding AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Carpenter Technology Corporation, Kuraray Co., Ltd., and Henry Schein, Inc. are a few of the key players in the North American dental biomaterials market.